Spinal muscular atrophy: A clinical and research update

Pediatric Neurology

Volumn 46, Issue 1, 2012, Pages 1-12

  Markowitz, Jennifer A ^a   Singh, Priyamvada ^a   Darras, Basil T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC G 418; ANTISENSE OLIGONUCLEOTIDE; ARYLBUTYRIC ACID DERIVATIVE; CARNITINE; GABAPENTIN; HYDROXAMIC ACID; HYDROXYUREA; RILUZOLE; SALBUTAMOL; SURVIVAL MOTOR NEURON PROTEIN; SURVIVAL MOTOR NEURON PROTEIN 1; VALPROIC ACID;

AUTOSOMAL RECESSIVE DISORDER; CELL THERAPY; CHROMOSOME 5Q; CLINICAL RESEARCH; DIAGNOSTIC TEST; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; HUMAN; LIFE EXPECTANCY; MUSCLE ATROPHY; MUSCLE WEAKNESS; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPINAL MUSCULAR ATROPHY; TRANSLATIONAL RESEARCH;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; MUSCULAR ATROPHY, SPINAL; QUALITY OF LIFE; SMN COMPLEX PROTEINS;

EID: 84555218229     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2011.09.001     Document Type: Review

References (134)

1. U.R. Monani, C.L. Lorson, and D.W. Parsons A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2 Hum Mol Genet 8 1999 1177 1183 (Pubitemid 29328985)
2. J. Pearn Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy J Med Genet 15 1978 409 413 (Pubitemid 9093440)
3. S. Ogino, D.G. Leonard, H. Rennert, W.J. Ewens, and R.B. Wilson Genetic risk assessment in carrier testing for spinal muscular atrophy Am J Med Genet 110 2002 301 307 (Pubitemid 34701042)
4. S. Ogino, R.B. Wilson, and B. Gold New insights on the evolution of the SMN1 and SMN2 region: Simulation and meta-analysis for allele and haplotype frequency calculations Eur J Hum Genet 12 2004 1015 1023 (Pubitemid 39600129)
5. M.L. Mostacciuolo, G.A. Danieli, C. Trevisan, E. Muller, and C. Angelini Epidemiology of spinal muscular atrophies in a sample of the Italian population Neuroepidemiology 11 1992 34 38
6. A. Thieme, B. Mitulla, F. Schulze, and A.W. Spiegler Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thuringen) Hum Genet 91 1993 295 297 (Pubitemid 23159205)
7. M.D. Mailman, J.W. Heinz, and A.C. Papp Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2 Genet Med 4 2002 20 26 (Pubitemid 44698460)
8. T. Zaldivar, Y. Montejo, and A.M. Acevedo Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population Neurology 65 2005 636 638 (Pubitemid 41170734)
9. B.C. Hendrickson, C. Donohoe, and V.R. Akmaev Differences in SMN1 allele frequencies among ethnic groups within North America J Med Genet 46 2009 641 644
10. T.W. Prior, P.J. Snyder, and B.D. Rink Newborn and carrier screening for spinal muscular atrophy Am J Med Genet [A] 152A 2010 1608 1616
11. K. Zerres, and K.E. Davies 59th ENMC International Workshop: Spinal muscular atrophies: Recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands Neuromuscul Disord 9 1999 272 278 (Pubitemid 29287265)
12. V. Dubowitz Chaos in the classification of SMA: A possible resolution Neuromuscul Disord 5 1995 3 5
13. S.T. Iannaccone, B.S. Russman, R.H. Browne, C.R. Buncher, M. White, and F.J. Samaha Prospective analysis of strength in spinal muscular atrophy: DCN/Spinal Muscular Atrophy Group J Child Neurol 15 2000 97 101 (Pubitemid 30139873)
14. C.H. Wang, R.S. Finkel, and E.S. Bertini Consensus statement for standard of care in spinal muscular atrophy J Child Neurol 22 2007 1027 1049 (Pubitemid 47308318)
15. J.M. O'Hagen, A.M. Glanzman, and M.P. McDermott An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients Neuromuscul Disord 17 2007 693 697 (Pubitemid 47362680)
16. N.H. Thomas, and V. Dubowitz The natural history of type I (severe) spinal muscular atrophy Neuromuscul Disord 4 1994 497 502 (Pubitemid 24331538)
17. T.O. Crawford Spinal muscular atrophies H.R.J. Jones, D.C. De Vivo, B.T. Darras, Neuromuscular disorders of infancy, childhood, and adolescence: A clinician's approach 2003 Butterworth Heinemann Philadelphia 145 166
18. L.A. Menke, B.T. Poll-The, and S.A. Clur Congenital heart defects in spinal muscular atrophy type I: A clinical report of two siblings and a review of the literature Am J Med Genet [A] 146A 2008 740 744 (Pubitemid 351354149)
19. S. Rudnik-Schöneborn, R. Heller, and C. Berg Congenital heart disease is a feature of severe infantile spinal muscular atrophy J Med Genet 45 2008 635 638
20. C.R. Heier, R. Satta, C. Lutz, and C.J. DiDonato Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice Hum Mol Genet 19 2010 3906 3918
21. A.K. Bevan, K.R. Hutchinson, and K.D. Foust Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery Hum Mol Genet 19 2010 3895 3905
22. M. Shababi, J. Habibi, H.T. Yang, S.M. Vale, W.A. Sewell, and C.L. Lorson Cardiac defects contribute to the pathology of spinal muscular atrophy models Hum Mol Genet 19 2010 4059 4071
23. S. Rudnik-Schöneborn, S. Vogelgesang, S. Armbrust, L. Graul-Neumann, C. Fusch, and K. Zerres Digital necroses and vascular thrombosis in severe spinal muscular atrophy Muscle Nerve 42 2010 144 147
24. Q. Araujo Ade, M. Araujo, and K.J. Swoboda Vascular perfusion abnormalities in infants with spinal muscular atrophy J Pediatr 155 2009 292 294
25. S. Rudnik-Schöneborn, H.H. Goebel, and W. Schlote Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy Neurology 60 2003 983 987 (Pubitemid 36348932)
26. D.M. Sproule, J. Montes, and M. Montgomery Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy Neuromuscul Disord 19 2009 391 396
27. A. von Gontard, K. Zerres, and M. Backes Intelligence and cognitive function in children and adolescents with spinal muscular atrophy Neuromuscul Disord 12 2002 130 136 (Pubitemid 33152730)
28. K. Zerres, S. Rudnik-Schöneborn, E. Forrest, A. Lusakowska, J. Borkowska, and I. Hausmanowa-Petrusewicz A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients J Neurol Sci 146 1997 67 72
29. M.J. MacLeod, J.E. Taylor, P.W. Lunt, C.G. Mathew, and S.A. Robb Prenatal onset spinal muscular atrophy Eur J Paediatr Neurol 3 1999 65 72 (Pubitemid 29193245)
30. V. Dubowitz Very severe spinal muscular atrophy (SMA type 0): An expanding clinical phenotype Eur J Paediatr Neurol 3 1999 49 51 (Pubitemid 29193242)
31. P.M. Bingham, N. Shen, and H. Rennert Arthrogryposis due to infantile neuronal degeneration associated with deletion of the SMNT gene Neurology 49 1997 848 851 (Pubitemid 27428034)
32. R. Korinthenberg, M. Sauer, and U.P. Ketelsen Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region Ann Neurol 42 1997 364 368 (Pubitemid 27391121)
33. B.S. Russman Spinal muscular atrophy: Clinical classification and disease heterogeneity J Child Neurol 22 2007 946 951 (Pubitemid 47308307)
34. N. Guillot, J.M. Cuisset, J.C. Cuvellier, J.F. Hurtevent, S. Joriot, and L. Vallee Unusual clinical features in infantile spinal muscular atrophies Brain Dev 30 2008 169 178 (Pubitemid 351258235)
35. B.T. Darras Non-5q spinal muscular atrophies: The alphanumeric soup thickens Neurology 77 2011 312 314
36. S. Lefebvre, L. Burglen, and S. Reboullet Identification and characterization of a spinal muscular atrophy-determining gene Cell 80 1995 155 165
37. C.L. Lorson, and E.J. Androphy An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN Hum Mol Genet 9 2000 259 265
38. S. Lefebvre, P. Burlet, and Q. Liu Correlation between severity and SMN protein level in spinal muscular atrophy Nat Genet 16 1997 265 269 (Pubitemid 27280210)
39. T.W. Prior Spinal muscular atrophy diagnostics J Child Neurol 22 2007 952 956 (Pubitemid 47308308)
40. C. DiDonato, S. Ingraham, and J. Mendell Deletions and conversion in spinal muscular atrophy patients: Is there a relationship to severity? Ann Neurol 41 1997 230 237 (Pubitemid 27082104)
41. G. van der Steege, P.M. Grootscholten, and J.M. Cobben Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5 Am J Hum Genet 59 1996 834 838 (Pubitemid 26328079)
42. L. Campbell, A. Potter, J. Ignatius, V. Dubowitz, and K. Davies Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype Am J Hum Genet 61 1997 40 50 (Pubitemid 27323322)
43. M. Feldkotter, V. Schwarzer, R. Wirth, T.F. Wienker, and B. Wirth Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy Am J Hum Genet 70 2002 358 368 (Pubitemid 34112291)
44. E. Arkblad, M. Tulinius, A.K. Kroksmark, M. Henricsson, and N. Darin A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy Acta Paediatr Scand 98 2009 865 872
45. M. Saito, Y. Chen, M. Mizuguchi, and T. Igarashi Quantitative analysis of SMN2 based on real-time PCR: Correlation of clinical severity and SMN2 gene dosage [in Japanese] No To Hattatsu 37 2005 407 412 (Pubitemid 41355402)
46. S. Rudnik-Schöneborn, C. Berg, and K. Zerres Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: Implications for clinical trials and genetic counselling Clin Genet 76 2009 168 178
47. T.W. Prior, K.J. Swoboda, H.D. Scott, and A.Q. Hejmanowski Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2 Am J Med Genet [A] 130A 2004 307 310 (Pubitemid 39313235)
48. T.W. Prior, A.R. Krainer, and Y. Hua A positive modifier of spinal muscular atrophy in the SMN2 gene Am J Hum Genet 85 2009 408 413
49. G.E. Oprea, S. Krober, and M.L. McWhorter Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy Science 320 2008 524 527 (Pubitemid 351590664)
50. G. Stratigopoulos, P. Lanzano, and L. Deng Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females Arch Neurol 67 2010 1252 1256
51. C.J. Sumner, S.J. Kolb, and G.G. Harmison SMN mRNA and protein levels in peripheral blood: Biomarkers for SMA clinical trials Neurology 66 2006 1067 1073 (Pubitemid 44044793)
52. Prior TW, Russman BS. Spinal muscular atrophy. In: Pagon RA, Bird TC, Dolan CR, Stephens K, eds. GeneReviews, 1993-2000 [updated April 3, 2006]. Seattle, WA: University of Washington (online).
53. P.E. McAndrew, D.W. Parsons, and L.R. Simard Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number Am J Hum Genet 60 1997 1411 1422 (Pubitemid 27258073)
54. T. Eggermann, K. Zerres, D. Anhuf, D. Kotzot, C. Fauth, and S. Rudnik-Schöneborn Somatic mosaicism for a heterozygous deletion of the survival motor neuron (SMN1) gene Eur J Hum Genet 13 2005 309 313 (Pubitemid 40360785)
55. M. Smith, V. Calabro, B. Chong, N. Gardiner, S. Cowie, and D. du Sart Population screening and cascade testing for carriers of SMA Eur J Hum Genet 15 2007 759 766 (Pubitemid 46965409)
56. K.J. Swoboda, T.W. Prior, and C.B. Scott Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function Ann Neurol 57 2005 704 712 (Pubitemid 40628859)
57. ACOG Committee Opinion no. 432: Spinal muscular atrophy Obstet Gynecol 113 2009 1194 1196
58. J.M. Gitlin, K. Fischbeck, and T.O. Crawford Carrier testing for spinal muscular atrophy Genet Med 12 2010 621 622
59. R. Martinez-Hernandez, C. Soler-Botija, and E. Also The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation J Neuropathol Exp Neurol 68 2009 474 481
60. Q. Liu, and G. Dreyfuss A novel nuclear structure containing the survival of motor neurons protein EMBO J 15 1996 3555 3565 (Pubitemid 26239768)
61. H. Zhang, L. Xing, W. Rossoll, H. Wichterle, R.H. Singer, and G.J. Bassell Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons J Neurosci 26 2006 8622 8632 (Pubitemid 44316191)
62. G. Meister, S. Hannus, and O. Plottner SMNrp is an essential pre-mRNA splicing factor required for the formation of the mature spliceosome EMBO J 20 2001 2304 2314 (Pubitemid 32410599)
63. L. Pellizzoni, J. Yong, and G. Dreyfuss Essential role for the SMN complex in the specificity of snRNP assembly Science 298 2002 1775 1779 (Pubitemid 35404118)
64. S.J. Kolb, D.J. Battle, and G. Dreyfuss Molecular functions of the SMN complex J Child Neurol 22 2007 990 994 (Pubitemid 47308313)
65. D. Cheng, J. Cote, S. Shaaban, and M.T. Bedford The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing Mol Cell 25 2007 71 83 (Pubitemid 46049059)
66. W. Rossoll, S. Jablonka, and C. Andreassi SMN, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons J Cell Biol 163 2003 801 812 (Pubitemid 37517887)
67. U.R. Monani, M. Sendtner, and D.D. Coovert The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in SMN(-/-) mice and results in a mouse with spinal muscular atrophy Hum Mol Genet 9 2000 333 339 (Pubitemid 30098725)
68. H.M. Hsieh-Li, J.G. Chang, and Y.J. Jong A mouse model for spinal muscular atrophy Nat Genet 24 2000 66 70 (Pubitemid 30041423)
69. C.E. Beattie, T.L. Carrel, and M.L. McWhorter Fishing for a mechanism: Using zebrafish to understand spinal muscular atrophy J Child Neurol 22 2007 995 1003 (Pubitemid 47308314)
70. M.L. McWhorter, U.R. Monani, A.H. Burghes, and C.E. Beattie Knockdown of the survival motor neuron (SMN) protein in zebrafish causes defects in motor axon outgrowth and pathfinding J Cell Biol 162 2003 919 931 (Pubitemid 37087731)
71. M. Bowerman, C.L. Anderson, A. Beauvais, P.P. Boyl, W. Witke, and R. Kothary SMN, profilin IIa and plastin 3: A link between the deregulation of actin dynamics and SMA pathogenesis Mol Cell Neurosci 42 2009 66 74
72. T. Voigt, K. Meyer, O. Baum, and D. Schumperli Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for spinal muscular atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing Neuromuscul Disord 20 2010 744 752
73. 2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice J Neurosci 30 2010 849 857
74. L. Kong, X. Wang, and D.W. Choe Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice J Neurosci 29 2009 842 851
75. K.L. Boon, S. Xiao, and M.L. McWhorter Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects Hum Mol Genet 18 2009 3615 3625
76. W. Rossoll, and G.J. Bassell Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes Results Probl Cell Differ 48 2009 289 326
77. S. Kariya, G.H. Park, and Y. Maeno-Hikichi Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy Hum Mol Genet 17 2008 2552 2569
78. T.O. Crawford Concerns about the design of clinical trials for spinal muscular atrophy Neuromuscul Disord 14 2004 456 460 (Pubitemid 39141699)
79. J.S. Wu, B.T. Darras, and S.B. Rutkove Assessing spinal muscular atrophy with quantitative ultrasound Neurology 75 2010 526 531
80. J. Montes, M.P. McDermott, and W.B. Martens Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy Neurology 74 2010 833 838
81. A.M. Glanzman, E. Mazzone, and M. Main The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability Neuromuscul Disord 20 2010 155 161
82. L. Nelson, H. Owens, L.S. Hynan, and S.T. Iannaccone The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy Neuromuscul Disord 16 2006 374 380 (Pubitemid 43870324)
83. M. Main, H. Kairon, E. Mercuri, and F. Muntoni The Hammersmith Functional Motor Scale for children with spinal muscular atrophy: A scale to test ability and monitor progress in children with limited ambulation Eur J Paediatr Neurol 7 2003 155 159 (Pubitemid 36939996)
84. K.J. Krosschell, J.A. Maczulski, T.O. Crawford, C. Scott, and K.J. Swoboda A modified Hammersmith Functional Motor Scale for use in multi-center research on spinal muscular atrophy Neuromuscul Disord 16 2006 417 426 (Pubitemid 44109971)
85. J. Montes, A.M. Gordon, S. Pandya, D.C. De Vivo, and P. Kaufmann Clinical outcome measures in spinal muscular atrophy J Child Neurol 24 2009 968 978
86. L.K. Tsai, C.C. Yang, C.H. Ting, Y.N. Su, W.L. Hwu, and H. Li Correlation of survival motor neuron expression in leukocytes and spinal cord in spinal muscular atrophy J Pediatr 154 2009 303 305
87. F.D. Tiziano, A.M. Pinto, and S. Fiori SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR Eur J Hum Genet 18 2010 52 58
88. S.T. Iannaccone, L.S. Hynan, A. Morton, R. Buchanan, C.A. Limbers, and J.W. Varni The PedsQL in pediatric patients with spinal muscular atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module Neuromuscul Disord 19 2009 805 812
89. B.T. Darras, and P.B. Kang Clinical trials in spinal muscular atrophy Curr Opin Pediatr 19 2007 675 679 (Pubitemid 350145236)
90. S. Lunke, and A. El-Osta The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy J Neurochem 109 2009 1557 1569
91. J.G. Chang, H.M. Hsieh-Li, Y.J. Jong, N.M. Wang, C.H. Tsai, and H. Li Treatment of spinal muscular atrophy by sodium butyrate Proc Natl Acad Sci USA 98 2001 9808 9813 (Pubitemid 32769385)
92. C. Andreassi, C. Angelozzi, and F.D. Tiziano Phenylbutyrate increases SMN expression in vitro: Relevance for treatment of spinal muscular atrophy Eur J Hum Genet 12 2004 59 65 (Pubitemid 38180971)
93. C. Brahe, T. Vitali, and F.D. Tiziano Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients Eur J Hum Genet 13 2005 256 259 (Pubitemid 40220572)
94. E. Mercuri, E. Bertini, and S. Messina Pilot trial of phenylbutyrate in spinal muscular atrophy Neuromuscul Disord 14 2004 130 135 (Pubitemid 38083321)
95. E. Mercuri, E. Bertini, and S. Messina Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy Neurology 68 2007 51 55 (Pubitemid 46058552)
96. C.J. Sumner, T.N. Huynh, and J.A. Markowitz Valproic acid increases SMN levels in spinal muscular atrophy patient cells Ann Neurol 54 2003 647 654 (Pubitemid 37346071)
97. L. Brichta, Y. Hofmann, and E. Hahnen Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy Hum Mol Genet 12 2003 2481 2489 (Pubitemid 37220412)
98. K.J. Swoboda, C.B. Scott, and S.P. Reyna Phase II open label study of valproic acid in spinal muscular atrophy PLoS One 4 2009 e5268
99. K.J. Swoboda, C.B. Scott, and T.O. Crawford SMA CARNI-VAL Trial part I: Double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy PLoS One 5 2010 e12140
100. L. Garbes, M. Riessland, and I. Holker LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate Hum Mol Genet 18 2009 3645 3658
101. S.M. Grzeschik, M. Ganta, T.W. Prior, W.D. Heavlin, and C.H. Wang Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells Ann Neurol 58 2005 194 202 (Pubitemid 41098877)
102. W.C. Liang, C.Y. Yuo, and J.G. Chang The effect of hydroxyurea in spinal muscular atrophy cells and patients J Neurol Sci 268 2008 87 94
103. C. Xu, X. Chen, S.M. Grzeschik, M. Ganta, and C.H. Wang Hydroxyurea enhances SMN2 gene expression through nitric oxide release Neurogenetics 12 2011 19 24
104. T.H. Chen, J.G. Chang, and Y.H. Yang Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy Neurology 75 2010 2190 2197
105. M. Kinali, E. Mercuri, and M. Main Pilot trial of albuterol in spinal muscular atrophy Neurology 59 2002 609 610 (Pubitemid 34919999)
106. M. Pane, S. Staccioli, and S. Messina Daily salbutamol in young patients with SMA type II Neuromuscul Disord 18 2008 536 540
107. F.D. Tiziano, R. Lomastro, and A.M. Pinto Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: Relevance for clinical trial design J Med Genet 47 2010 856 858
108. C. Angelozzi, F. Borgo, F.D. Tiziano, A. Martella, G. Neri, and C. Brahe Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells J Med Genet 45 2008 29 31 (Pubitemid 351158155)
109. E.C. Wolstencroft, V. Mattis, A.A. Bajer, P.J. Young, and C.L. Lorson A non-sequence-specific requirement for SMN protein activity: The role of aminoglycosides in inducing elevated SMN protein levels Hum Mol Genet 14 2005 1199 1210 (Pubitemid 40613908)
110. C.R. Heier, and C.J. DiDonato Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo Hum Mol Genet 18 2009 1310 1322
111. H. Haddad, C. Cifuentes-Diaz, A. Miroglio, N. Roblot, V. Joshi, and J. Melki Riluzole attenuates spinal muscular atrophy disease progression in a mouse model Muscle Nerve 28 2003 432 437 (Pubitemid 37193770)
112. B.S. Russman, S.T. Iannaccone, and F.J. Samaha A phase 1 trial of riluzole in spinal muscular atrophy Arch Neurol 60 2003 1601 1603 (Pubitemid 37443126)
113. R.G. Miller, D.H. Moore, and V. Dronsky A placebo-controlled trial of gabapentin in spinal muscular atrophy J Neurol Sci 191 2001 127 131 (Pubitemid 33035905)
114. L. Merlini, A. Solari, and G. Vita Role of gabapentin in spinal muscular atrophy: Results of a multicenter, randomized Italian study J Child Neurol 18 2003 537 541 (Pubitemid 37098628)
115. O. Biondi, J. Branchu, and G. Sanchez In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice J Neurosci 30 2010 11288 11299
116. A.H. Burghes, and V.L. McGovern Antisense oligonucleotides and spinal muscular atrophy: Skipping along Genes Dev 24 2010 1574 1579
117. Y. Hua, T.A. Vickers, H.L. Okunola, C.F. Bennett, and A.R. Krainer Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice Am J Hum Genet 82 2008 834 848
118. N.N. Singh, M. Shishimorova, L.C. Cao, L. Gangwani, and R.N. Singh A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy RNA Biol 6 2009 341 350
119. Y. Hua, K. Sahashi, and G. Hung Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model Genes Dev 24 2010 1634 1644
120. J.H. Williams, R.C. Schray, C.A. Patterson, S.O. Ayitey, M.K. Tallent, and G.J. Lutz Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy J Neurosci 29 2009 7633 7638
121. T.D. Baughan, A. Dickson, E.Y. Osman, and C.L. Lorson Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy Hum Mol Genet 18 2009 1600 1611
122. T. Geib, and K.J. Hertel Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs PLoS One 4 2009 e8204
123. S. Corti, M. Nizzardo, and M. Nardini Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice Brain 133 2010 465 481
124. A.D. Ebert, J. Yu, and F.F. Rose Jr. Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 2009 277 280
125. K.D. Foust, X. Wang, and V.L. McGovern Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN Nat Biotechnol 28 2010 271 274
126. M.A. Passini, J. Bu, and E.M. Roskelley CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy J Clin Invest 120 2010 1253 1264
127. S.T. Iannaccone Modern management of spinal muscular atrophy J Child Neurol 22 2007 974 978 (Pubitemid 47308311)
128. M.K. Schroth Special considerations in the respiratory management of spinal muscular atrophy Pediatrics 123 Suppl. 4 2009 S245 S249
129. U. Mellies, C. Dohna-Schwake, F. Stehling, and T. Voit Sleep disordered breathing in spinal muscular atrophy Neuromuscul Disord 14 2004 797 803 (Pubitemid 39582719)
130. A. Markstrom, G. Cohen, and M. Katz-Salamon The effect of long term ventilatory support on hemodynamics in children with spinal muscle atrophy (SMA) type II Sleep Med 11 2010 201 204
131. E.T. Durkin, M.K. Schroth, M. Helin, and A.F. Shaaban Early laparoscopic fundoplication and gastrostomy in infants with spinal muscular atrophy type I J Pediatr Surg 43 2008 2031 2037
132. N. Yuan, C.H. Wang, A. Trela, and C.T. Albanese Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy J Child Neurol 22 2007 727 731 (Pubitemid 47034378)
133. D.M. Sproule, J. Montes, and S. Dunaway Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy Neuromuscul Disord 20 2010 448 452
134. A. Fujak, C. Kopschina, R. Forst, F. Gras, L.A. Mueller, and J. Forst Fractures in proximal spinal muscular atrophy Arch Orthop Trauma Surg 130 2010 775 780